GE HealthCare Technologies Net Income 2020-2023 | GEHC
GE HealthCare Technologies annual/quarterly net income history and growth rate from 2020 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- GE HealthCare Technologies net income for the quarter ending December 31, 2023 was $0.403B, a 27.39% decline year-over-year.
- GE HealthCare Technologies net income for the twelve months ending December 31, 2023 was $1.385B, a 27.71% decline year-over-year.
- GE HealthCare Technologies annual net income for 2023 was $1.385B, a 27.71% decline from 2022.
- GE HealthCare Technologies annual net income for 2022 was $1.916B, a 14.73% decline from 2021.
- GE HealthCare Technologies annual net income for 2021 was $2.247B, a 83.77% decline from 2020.
| GE HealthCare Technologies Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $1,385 |
| 2022 | $1,916 |
| 2021 | $2,247 |
| 2020 | $13,846 |
| 2019 | $1,524 |
| GE HealthCare Technologies Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | $403 |
| 2023-09-30 | $375 |
| 2023-06-30 | $418 |
| 2023-03-31 | $189 |
| 2022-12-31 | $555 |
| 2022-09-30 | $487 |
| 2022-06-30 | $485 |
| 2022-03-31 | $389 |
| 2021-12-31 | |
| 2021-09-30 | |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $39.221B | $19.552B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems (INSP) | United States | $6.999B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.463B | 0.00 |
| Axonics (AXNX) | United States | $3.394B | 0.00 |
| 10x Genomics (TXG) | United States | $3.206B | 0.00 |
| Enovis (ENOV) | United States | $3.022B | 22.96 |
| Azenta (AZTA) | United States | $2.872B | 234.09 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.869B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.629B | 0.00 |
| Privia Health (PRVA) | United States | $2.135B | 94.68 |
| Schrodinger (SDGR) | United States | $1.688B | 0.00 |
| Omnicell (OMCL) | United States | $1.246B | 30.48 |
| Phreesia (PHR) | United States | $1.154B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.793B | 0.00 |
| Standard BioTools (LAB) | United States | $0.685B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
| Talkspace (TALK) | United States | $0.520B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.332B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.328B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.323B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| American Well (AMWL) | United States | $0.156B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.152B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.147B | 0.00 |
| Augmedix (AUGX) | United States | $0.136B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.131B | 0.00 |
| Outset Medical (OM) | United States | $0.123B | 0.00 |
| TruBridge (TBRG) | United States | $0.115B | 4.91 |
| 111 (YI) | China | $0.084B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.077B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.045B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
| Movano (MOVE) | United States | $0.027B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |